Unknown

Dataset Information

0

Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice.

ABSTRACT: TET1/2/3 are methylcytosine dioxygenases that regulate cytosine hydroxymethylation. Tet1/2 are abundantly expressed in HSC/HPCs and are implicated in hematological malignancies. Tet2 deletion in mice causes myeloid malignancies, while Tet1-null mice develop B cell lymphoma after an extended period of latency. Interestingly, TET1/2 are often concomitantly downregulated in acute B-lymphocytic leukemia. Here, we investigated the overlapping and non-redundant functions of Tet1/2 using Tet1/2 double-knockout (DKO) mice. DKO and Tet2(-/-) HSC/HPCs show overlapping and unique 5 hmC and 5 mC profiles. DKO mice exhibit strikingly decreased incidence and delayed onset of myeloid malignancies in comparison to Tet2(-/-) mice and in contrast develop lethal B cell malignancies. Transcriptome analysis of DKO tumors reveals expression changes in many genes dysregulated in human B cell malignancies, including LMO2, BCL6, and MYC. These results highlight the critical roles of TET1/2 individually and together in the pathogenesis of hematological malignancies.

SUBMITTER: Zhao Z 

PROVIDER: S-EPMC4764044 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

TET1/2/3 are methylcytosine dioxygenases that regulate cytosine hydroxymethylation. Tet1/2 are abundantly expressed in HSC/HPCs and are implicated in hematological malignancies. Tet2 deletion in mice causes myeloid malignancies, while Tet1-null mice develop B cell lymphoma after an extended period of latency. Interestingly, TET1/2 are often concomitantly downregulated in acute B-lymphocytic leukemia. Here, we investigated the overlapping and non-redundant functions of Tet1/2 using Tet1/2 double-  ...[more]

Similar Datasets

Transcriptomics Combined loss of Tet1 and Tet2 promotes B-cell, but not myeloid malignancies in mice
2015-11-12 | E-GEOD-73611 | biostudies-arrayexpress
Transcriptomics Combined loss of Tet1 and Tet2 promotes B-cell, but not myeloid malignancies in mice
2015-11-12 | GSE73611 | GEO
Unknown Loss of Asxl2 leads to myeloid malignancies in mice.
| S-EPMC5472177 | biostudies-literature
Unknown The Loss of TET2 Promotes CD8+ T Cell Memory Differentiation.
| S-EPMC5736442 | biostudies-literature
Unknown Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
| S-EPMC3952630 | biostudies-literature
Unknown Inhibition of Tet1- and Tet2-mediated DNA demethylation promotes immunomodulation of periodontal ligament stem cells.
| S-EPMC6791886 | biostudies-other
Unknown Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
| S-EPMC3194039 | biostudies-literature
Unknown Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development.
| S-EPMC3574201 | biostudies-literature
Unknown ETV2-TET1/TET2 Complexes Induce Endothelial Cell-Specific Robo4 Expression via Promoter Demethylation.
| S-EPMC5884809 | biostudies-other
Unknown Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis.
| S-EPMC4731232 | biostudies-literature